There is a need for non-invasive biomarkers that enable accurate tracking of early, pre-symptomatic phases of Alzheimer’s disease (AD). Previous fMRI studies have differentiated AD patients from healthy controls. However, it is unknown whether the accumulation of tau or amyloid pathology is driving the fMRI irregularity. This is the first study to investigate whether tau pathology alone can modulate task-based BOLD fMRI. We observed stronger BOLD responses to visual stimulation in lateral geniculate nucleus and superior colliculus in the tau cohort, mirroring observations in mild AD and MCI patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords